(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with kallidin in 1 studies
Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Studies (kallidin) | Trials (kallidin) | Recent Studies (post-2010) (kallidin) |
---|---|---|---|---|---|
85 | 0 | 65 | 534 | 12 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allcock, BK; Gerovac, TA; McChesney, SL; Miranpuri, GS; Park, SW; Rajpal, S; Resnick, DK; Tilghman, JI; Turner, NA | 1 |
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and kallidin
Article | Year |
---|---|
Antihyperalgesic effects of vanilloid-1 and bradykinin-1 receptor antagonists following spinal cord injury in rats.
Topics: Acrylamides; Animals; Bradykinin Receptor Antagonists; Bridged Bicyclo Compounds, Heterocyclic; Hyperalgesia; Kallidin; Male; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; TRPV Cation Channels | 2007 |